The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention

Despite patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel therapy, some patients still experience major adverse cardiovascular events (MACEs). Clopidogrel resistance, which may be regulated by genetic and epigenetic factors, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Giantini, Astuti, Timan, Ina S., Dharma, Rahajuningsih, Sukmawan, Renan, Setiabudy, Rianto, Alwi, Idrus, Harahap, Alida R., Listiyaningsih, Erlin, Partakusuma, Lia G., Tansir, Arif R., Sahar, Windy, Hidayat, Rakhmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944402/
https://www.ncbi.nlm.nih.gov/pubmed/36843628
http://dx.doi.org/10.3389/fcvm.2022.1027892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944402/
https://www.ncbi.nlm.nih.gov/pubmed/36843628
http://dx.doi.org/10.3389/fcvm.2022.1027892

Ejemplares similares